# Baijin Life Science Holdings Limited (MNNGF)

> Healthcare · HK · Reports in HKD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MNNGF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | HK$ 89.25M | HK$ -37.85M | HK$ -22.55M | HK$ 28.40M | HK$ 185.09M |
| 2025 | HK$ 135.56M | HK$ -316.0K | HK$ -32.97M | HK$ 99.93M | HK$ 139.28M |
| 2024 | HK$ 41.12M | HK$ -7.45M | HK$ -5.63M | HK$ 51.19M | HK$ 96.31M |
| 2023 | HK$ 86.88M | HK$ 8.68M | HK$ -22.84M | HK$ 2.76M | HK$ 78.34M |
| 2022 | HK$ 62.65M | HK$ -15.46M | HK$ -2.14M | HK$ 31.84M | HK$ 35.87M |
| 2021 | HK$ 43.32M | HK$ -51.79M | HK$ -20.39M | HK$ 31.56M | HK$ 45.95M |
| 2020 | HK$ 111.98M | HK$ -281.82M | HK$ -8.25M | HK$ 39.50M | HK$ 85.13M |
| 2019 | HK$ 171.27M | HK$ -42.82M | HK$ -24.04M | HK$ 52.50M | HK$ 197.98M |
| 2018 | HK$ 187.36M | HK$ -129.79M | HK$ 81.95M | HK$ 0 | HK$ 236.51M |
| 2017 | HK$ 212.23M | HK$ -23.89M | HK$ -89.70M | HK$ 0 | HK$ 290.09M |
| 2016 | HK$ 210.02M | HK$ -10.94M | HK$ -20.97M | HK$ 0 | HK$ 313.66M |
| 2015 | HK$ 270.71M | HK$ 10.06M | HK$ -17.48M | HK$ 45.20M | HK$ 267.60M |
| 2014 | HK$ 268.47M | HK$ 29.60M | HK$ 19.50M | HK$ 47.60M | HK$ 398.86M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.15 |
| Liabilities / Eq | 0.39 |
| Current Ratio | 2.97 |

## Other views

- [Metrics](https://sponda.capital/en/MNNGF.md)
- [Charts](https://sponda.capital/en/MNNGF/charts.md)
- [Compare](https://sponda.capital/en/MNNGF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.